Literature DB >> 25028517

The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions.

Keriann M Backus1, Michael A Dolan2, Conor S Barry3, Maju Joe4, Peter McPhie5, Helena I M Boshoff6, Todd L Lowary4, Benjamin G Davis7, Clifton E Barry8.   

Abstract

The three isoforms of antigen 85 (A, B, and C) are the most abundant secreted mycobacterial proteins and catalyze transesterification reactions that synthesize mycolated arabinogalactan, trehalose monomycolate (TMM), and trehalose dimycolate (TDM), important constituents of the outermost layer of the cellular envelope of Mycobacterium tuberculosis. These three enzymes are nearly identical at the active site and have therefore been postulated to exist to evade host immunity. Distal to the active site is a second putative carbohydrate-binding site of lower homology. Mutagenesis of the three isoforms at this second site affected both substrate selectivity and overall catalytic activity in vitro. Using synthetic and natural substrates, we show that these three enzymes exhibit unique selectivity; antigen 85A more efficiently mycolates TMM to form TDM, whereas C (and to a lesser extent B) has a higher rate of activity using free trehalose to form TMM. This difference in substrate selectivity extends to the hexasaccharide fragment of cell wall arabinan. Mutation of secondary site residues from the most active isoform (C) into those present in A or B partially interconverts this substrate selectivity. These experiments in combination with molecular dynamics simulations reveal that differences in the N-terminal helix α9, the adjacent Pro(216)-Phe(228) loop, and helix α5 are the likely cause of changes in activity and substrate selectivity. These differences explain the existence of three isoforms and will allow for future work in developing inhibitors.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Antigen 85; Cell Wall; Enzyme Mechanism; Glycolipid; Molecular Dynamics; Mycolyl Transferase; Trehalose; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 25028517      PMCID: PMC4155671          DOI: 10.1074/jbc.M114.581579

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.

Authors:  D R Ronning; T Klabunde; G S Besra; V D Vissa; J T Belisle; J C Sacchettini
Journal:  Nat Struct Biol       Date:  2000-02

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis.

Authors:  K Takayama; J O Kilburn
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 4.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

5.  Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.

Authors:  Aditya K Sanki; Julie Boucau; Francis E Umesiri; Donald R Ronning; Steven J Sucheck
Journal:  Mol Biosyst       Date:  2009-06-19

6.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

7.  A model for interfacial activation in lipases from the structure of a fungal lipase-inhibitor complex.

Authors:  A M Brzozowski; U Derewenda; Z S Derewenda; G G Dodson; D M Lawson; J P Turkenburg; F Bjorkling; B Huge-Jensen; S A Patkar; L Thim
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

8.  SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.

Authors:  Kapil Tahlan; Regina Wilson; David B Kastrinsky; Kriti Arora; Vinod Nair; Elizabeth Fischer; S Whitney Barnes; John R Walker; David Alland; Clifton E Barry; Helena I Boshoff
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

Review 9.  Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis.

Authors:  P J Brennan
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

10.  Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope.

Authors:  L Deng; K Mikusová; K G Robuck; M Scherman; P J Brennan; M R McNeil
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

View more
  25 in total

1.  The trehalose-specific transporter LpqY-SugABC is required for antimicrobial and anti-biofilm activity of trehalose analogues in Mycobacterium smegmatis.

Authors:  Jeffrey M Wolber; Bailey L Urbanek; Lisa M Meints; Brent F Piligian; Irene C Lopez-Casillas; Kailey M Zochowski; Peter J Woodruff; Benjamin M Swarts
Journal:  Carbohydr Res       Date:  2017-08-09       Impact factor: 2.104

2.  Structural and functional evidence that lipoprotein LpqN supports cell envelope biogenesis in Mycobacterium tuberculosis.

Authors:  Geoff C Melly; Haley Stokas; Jennifer L Dunaj; Fong Fu Hsu; Malligarjunan Rajavel; Chih-Chia Su; Edward W Yu; Georgiana E Purdy
Journal:  J Biol Chem       Date:  2019-08-30       Impact factor: 5.157

3.  Multisystem Analysis of Mycobacterium tuberculosis Reveals Kinase-Dependent Remodeling of the Pathogen-Environment Interface.

Authors:  Xavier Carette; John Platig; David C Young; Michaela Helmel; Albert T Young; Zhe Wang; Lakshmi-Prasad Potluri; Cameron Stuver Moody; Jumei Zeng; Sladjana Prisic; Joseph N Paulson; Jan Muntel; Ashoka V R Madduri; Jorge Velarde; Jacob A Mayfield; Christopher Locher; Tiansheng Wang; John Quackenbush; Kyu Y Rhee; D Branch Moody; Hanno Steen; Robert N Husson
Journal:  mBio       Date:  2018-03-06       Impact factor: 7.867

4.  Tailoring Trehalose for Biomedical and Biotechnological Applications.

Authors:  Mara K O'Neill; Brent F Piligian; Claire D Olson; Peter J Woodruff; Benjamin M Swarts
Journal:  Pure Appl Chem       Date:  2017-01-11       Impact factor: 2.453

5.  Mycolyltransferase from Mycobacterium tuberculosis in covalent complex with tetrahydrolipstatin provides insights into antigen 85 catalysis.

Authors:  Christopher M Goins; Steven Dajnowicz; Micholas D Smith; Jerry M Parks; Donald R Ronning
Journal:  J Biol Chem       Date:  2018-01-19       Impact factor: 5.157

6.  Deoxyfluoro-d-trehalose (FDTre) analogues as potential PET probes for imaging mycobacterial infection.

Authors:  Sarah R Rundell; Zachary L Wagar; Lisa M Meints; Claire D Olson; Mara K O'Neill; Brent F Piligian; Anne W Poston; Robin J Hood; Peter J Woodruff; Benjamin M Swarts
Journal:  Org Biomol Chem       Date:  2016-08-25       Impact factor: 3.876

7.  Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.

Authors:  Christopher M Goins; Steven Dajnowicz; Sandeep Thanna; Steven J Sucheck; Jerry M Parks; Donald R Ronning
Journal:  ACS Infect Dis       Date:  2017-03-21       Impact factor: 5.084

8.  Targeting the trehalose utilization pathways of Mycobacterium tuberculosis.

Authors:  Sandeep Thanna; Steven J Sucheck
Journal:  Medchemcomm       Date:  2015-10-16       Impact factor: 3.597

9.  Functional insights from a comparative study on the dynamics of Antigen85 proteins and MPT51 from Mycobacterium tuberculosis.

Authors:  Shobana Sundar; David Annaraj; Anitha Selvan; Pallavi Guha Biswas; Reshma Vijayakumaran; Sharmila Anishetty
Journal:  J Mol Model       Date:  2015-11-12       Impact factor: 1.810

10.  Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front-Line Tuberculosis Drugs.

Authors:  Frances P Rodriguez-Rivera; Xiaoxue Zhou; Julie A Theriot; Carolyn R Bertozzi
Journal:  Angew Chem Int Ed Engl       Date:  2018-04-14       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.